(Q41061299)

English

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study (English)
Anthony Cahn
Simon Hodgson
Robert Wilson
Jonathan Robertson
Joanna Watson
Misba Beerahee
Steve C Hughes
Rebecca Graves
Sjoerd van Marle
Roberto Solari
28 February 2013

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit